These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32772748)

  • 1. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
    Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
    Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
    Blanc-Durand F; Lefeuvre-Plesse C; Ray-Coquard I; Chaltiel D; Floquet A; Meriaux É; Berton D; Bello-Roufai D; Guillemet C; Dupre PF; Faller É; Alexandre J; Hardy-Bressard AC; Collard O; Fabbro M; Provansal M; Kalbacher E; Genestie C; Pautier P
    Gynecol Oncol; 2020 Oct; 159(1):129-135. PubMed ID: 32723678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
    Clarke BA; Witkowski L; Ton Nu TN; Shaw PA; Gilks CB; Huntsman D; Karnezis AN; Sebire N; Lamovec J; Roth LM; Stewart CJ; Hasselblatt M; Foulkes WD; McCluggage WG
    Histopathology; 2016 Nov; 69(5):727-738. PubMed ID: 27100627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
    Callegaro-Filho D; Gershenson DM; Nick AM; Munsell MF; Ramirez PT; Eifel PJ; Euscher ED; Marques RM; Nicolau SM; Schmeler KM
    Gynecol Oncol; 2016 Jan; 140(1):53-7. PubMed ID: 26546963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
    Chen X; Liu HL; Wang JS; Zhao FH
    Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
    Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.
    Witkowski L; Goudie C; Foulkes WD; McCluggage WG
    Surg Pathol Clin; 2016 Jun; 9(2):215-26. PubMed ID: 27241105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small cell carcinoma of ovary, hypercalcemic type: analysis of clinicopathologic characteristics and the diagnostic utility of loss expression of SMARCA4 protein].
    Wang L; Tan C; Tu X; Zhang Y; Li X; Chang B
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):859-63. PubMed ID: 26888501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
    Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.
    Tischkowitz M; Huang S; Banerjee S; Hague J; Hendricks WPD; Huntsman DG; Lang JD; Orlando KA; Oza AM; Pautier P; Ray-Coquard I; Trent JM; Witcher M; Witkowski L; McCluggage WG; Levine DA; Foulkes WD; Weissman BE
    Clin Cancer Res; 2020 Aug; 26(15):3908-3917. PubMed ID: 32156746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary.
    Jamy O; Yaghmour G; Hare F; Martin MG
    Anticancer Res; 2015 May; 35(5):3091-5. PubMed ID: 25964600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases.
    Sahay A; Kante K; Menon S; Ghosh J; Kerkar RA; Deodhar KK
    Turk Patoloji Derg; 2020; 1(1):261-267. PubMed ID: 32149361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Cell Carcinoma of the Ovary, Hypercalcemic Type, in a 12-Month-Old Girl.
    Atwi D; Quinton MR; Kiser RM; Pokala HR; Rooms LM; Yu Z
    Pediatr Dev Pathol; 2021; 24(5):493-497. PubMed ID: 34047234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
    Lin DI; Chudnovsky Y; Duggan B; Zajchowski D; Greenbowe J; Ross JS; Gay LM; Ali SM; Elvin JA
    Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
    Witkowski L; Goudie C; Ramos P; Boshari T; Brunet JS; Karnezis AN; Longy M; Knost JA; Saloustros E; McCluggage WG; Stewart CJR; Hendricks WPD; Cunliffe H; Huntsman DG; Pautier P; Levine DA; Trent JM; Berchuck A; Hasselblatt M; Foulkes WD
    Gynecol Oncol; 2016 Jun; 141(3):454-460. PubMed ID: 26975901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report.
    Coşkun Ç; Kurucu N; Usubutun A; Soyer T; Ozcan HN; Çelik Ertaş NB; Kutluk T
    J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):112-115. PubMed ID: 36243275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
    Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
    Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.
    Harrison ML; Hoskins P; du Bois A; Quinn M; Rustin GJ; Ledermann JA; Baron-Hay S; Friedlander ML
    Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.